Clinical Trial Update: Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy of sacubitril/valsartan in adults with non-obstructive hypertrophic cardiomyopathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cardiomyopathy, Hypertrophic | Phase 2 | Status: COMPLETED | Results posted: 2024-08-29